LifeCell Inherits Cryo-Save India's Preserved Umbilical Cord
Photo Credit :
Stem Cell Samples
(Attn.editors: The following press release comes to you under an arrangement with PRNewswire. PTI takes no editorial responsibility for the same).
LifeCell Inherits Cryo-Save India's Preserved Umbilical Cord Stem Cell Samples
CHENNAI, October 10, 2017/PRNewswire/ -- All 18,000+ Cryo- Save India customers and preserved umbilical cord stem cell units will now be serviced by LifeCell
There will be no change in the client agreement signed by customers with Cryo-Save India and LifeCell shall continue to service these customers
Cryo-Save India customers can now upgrade to BabyCord Share - LifeCell's community stem cell banking thereby extending the protection of stem cells to their entire family
LifeCell further strengthens its industry position with added inventory of stem cells. Further with upgrade to community banking will soon add more donor stem cells for unlimited family access of its members
LifeCell, India's first and largest umbilical cord stem cell bank has today announced signing of a formal agreement with Cryo-Save India (Cryo-Save) for formal transfer of all of its 18,000 cryopreserved umbilical cord units and corresponding customer agreements to LifeCell.
(Logo: http://mma.prnewswire.com/media/542620/LifeCell_Logo.jpg )
The cryopreserved stem cells currently under the care of Cryo-Save would be transported to LifeCell's preservation facility at Chennai. This transportation would occur in phases and is expected to take up to 3 months for completion.
Further to the reassignment of the agreement to LifeCell, the customers of Cryo-Save will have opportunities to reap greater benefits of the decision to preserve their baby's stem cells. Through LifeCell's community stem cell banking program, these customers can now upgrade to receive unlimited access to a large, growing inventory of donor stem cells to get complete protection of stem cells for the entire family. Furthermore, by upgrading to the Lifetime Storage Plan, the stem cell samples can be preserved for the entire lifetime of the baby.
Speaking on the occasion Mayur Abhaya, MD, CEO, LifeCell said , "This transfer marks an important step to expand our business by leveraging our infrastructure and storage standards. It would also further strengthen our endeavor of becoming the country's largest registry of cord blood stem cells. We are happy to welcome these 18,000 families into the ambit of our community and also extend benefits such as complete family protection and unlimited access to matching stem cells. We look forward to providing best-in-class service to the new members of the LifeCell family."
LifeCell's state-of-the-art storage facility in Chennai and Gurgaon currently houses more than 2,70,000 samples preserved umbilical cord blood and tissue stem cell units.
Roderick M Stuart, MD, Cryo-Save India said, "We are happy to enter into this transaction with LifeCell - India's first and largest stem cell bank which provides highest quality services. LifeCell's state-of-the-art facility, laboratory standards and excellent customer relations made a great match for us. We are happy that the families who had preserved with us would continue to be provided with same high-quality stem cell preservation service for years to come."
Cryo-Save AG the brand and trademark owner has been storing umbilical cord stem cells for families all over the world since the year 2000. Cryo-Save India Pvt. Ltd. stored its first sample in India in the year 2008 at their processing and storage facility in Bangalore.
LifeCell, established in 2004, is India's leading provider of preventive healthcare services for family wellness, such as stem cell banking and diagnostic testing, with facilities at Chennai and Gurgaon with a network spanning over 200 cities in India and abroad. BabyCord, LifeCell's umbilical cord stem cell preservation services, is world's second largest with over 50,000 parents preserving their baby's stem cells with it each year and over 2,70,000 parents already having trusted LifeCell.
With the recent launch of BabyCord Share, a community-based approach towards stem cell access, is a global first and aims to provide families in India better future access to stem cells than even currently possible in advanced countries such as the U.S. LifeCell's processing, storage and testing facilities are the most accredited having received recognitions from domestic and global bodies such as the AABB (formerly American Association of Blood Banks), College of American Pathologists, National Accreditation Board for Laboratories, World Health Organization, amongst many others, and is also US FDA registered.
BabyShield, LifeCell's preventive genetic screening and diagnostic testing services, is India's market leader for newborn screening services and recently forayed into prenatal screening.
Visit us at : http://www.lifecell.in
For More details, please contact LifeCell: Krutika Rajkumar Senior Manager Corporate Communications [email protected] Mob: +91-9884493607
Source: LifeCell International Private Limited PRNewswire OSS
Disclaimer: This story has not been edited by BW staff and is auto-generated from a syndicated feed.